Long noncoding RNA CHROMR regulates antiviral immunity in humans

Long noncoding RNAs (lncRNAs) have emerged as critical regulators of gene expression, yet their contribution to immune regulation in humans remains poorly understood. Here, we report that the primate-specific IncRNA CHROMR is induced by influenza A virus and SARS-CoV-2 infection and coordinates the...

Full description

Saved in:
Bibliographic Details
Published inProceedings of the National Academy of Sciences - PNAS Vol. 119; no. 37; pp. 1 - 9
Main Authors van Solingen, Coen, Cyr, Yannick, Scacalossi, Kaitlyn R., deVries, Maren, Barrett, Tessa J., de Jong, Annika, Gourvest, Morgane, Zhang, Tracy, Peled, Daniel, Kher, Raadhika, Cornwell, MacIntosh, Gildea, Michael A., Brown, Emily J., Fanucchi, Stephanie, Mhlanga, Musa M., Berger, Jeffrey S., Dittmann, Meike, Moore, Kathryn J.
Format Journal Article
LanguageEnglish
Published Washington National Academy of Sciences 13.09.2022
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Long noncoding RNAs (lncRNAs) have emerged as critical regulators of gene expression, yet their contribution to immune regulation in humans remains poorly understood. Here, we report that the primate-specific IncRNA CHROMR is induced by influenza A virus and SARS-CoV-2 infection and coordinates the expression of interferon-stimulated genes (ISGs) that execute antiviral responses. CHROMR depletion in human macrophages reduces histone acetylation at regulatory regions of ISG loci and attenuates ISG expression in response to microbial stimuli. Mechanistically, we show that CHROMR sequesters the interferon regulatory factor (IRF)-2-dependent transcriptional corepressor IRF2BP2, thereby licensing IRF-dependent signaling and transcription of the ISG network. Consequently, CHROMR expression is essential to restrict viral infection of macrophages. Our findings identify CHROMR as a key arbitrator of antiviral innate immune signaling in humans.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
Contributed by Kathryn J. Moore; received June 16, 2022; accepted July 25, 2022; reviewed by Katherine Fitzgerald and Tamer Sallam
Author contributions: C.v.S. and K.J.M. designed research; C.v.S., Y.C., K.R.S., M.d.V., T.J.B., A.d.J., M.G., T.Z., D.P., R.K., and M.C. performed research; C.v.S., Y.C., K.R.S., M.d.V., T.J.B., A.d.J., M.G., T.Z., D.P., R.K., M.C., M.A.G., E.J.B., S.F., M.M.M., J.S.B., M.D., and K.J.M. analyzed data; and C.v.S. and K.J.M. wrote the paper.
ISSN:0027-8424
1091-6490
1091-6490
DOI:10.1073/pnas.2210321119